Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Credit
03 mai 2023 09h15 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...